Safety and Efficacy Study of Transcatheter Closure of Ostium Secundum ASDs
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 125 participants.
Also called NCT02985684
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 125 participants
- Sponsor
- Registry
-
NCT02985684
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT02985684. Allocation not applicable; no masking; primary purpose treatment. Start 2017-03-10 (actual); primary completion 2018-07-30 (actual). Results posted on 2020-01-07.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety and Efficacy Study of Transcatheter Closure of Ostium Secundum ASDs
- Acronym
- ASSURED
- Condition
- Atrial Septal Defect
- Intervention (Device)
- GORE® CARDIOFORM ASD Occluder
- Lead sponsor
- W.L.Gore & Associates
Record details
- Record id
cardio:ct-nct02985684- Content hash
118966790863488d9103cce3e4ff6e256d203e426e2843e4a8b1f0a52d7f62f8